Coronary calcium score or CT angiography: which question does each answer?
A heart CT can help answer an important question about prevention or chest symptoms—but different scans reveal different things. A calcium score measures hardened plaque, while CT angiography shows the arteries and their narrowing in more detail. Understanding that difference helps you and your clinician choose the information that can actually guide your care.
You feel well but are unsure whether to start cholesterol medication. Or you have chest discomfort and need to understand its cause. Both situations can lead to a conversation about a “heart CT,” but they call for different questions—and sometimes different tests.
Coronary artery calcium scoring, or CAC, measures calcified plaque in the arteries supplying the heart. Coronary CT angiography, or CCTA, uses injected contrast to show the arteries, plaque and narrowing in more detail. [1] [2]
If you have new or worsening chest pain now, seek urgent medical assessment. For possible heart-attack symptoms, call 911 in the United States. A reassuring earlier scan is not a reason to wait. [3]
What each scan adds
Calcium score | CT angiography | |
|---|---|---|
Main information | Amount of calcified coronary plaque | Coronary anatomy, plaque and narrowing |
Injected contrast | Not required | Iodine-containing contrast through an IV |
A common purpose | Clarifying a preventive treatment decision | Investigating suspected coronary disease in a selected patient |
More detail is helpful when it answers the question that remains unresolved. The starting point is your symptoms, medical history and overall cardiovascular risk. [1] [2] [3]
When a calcium score can clarify prevention
Suppose your blood pressure, cholesterol, family history and other risk factors leave you and your clinician uncertain about preventive medication. Knowing whether coronary plaque is present may help make that decision more confidently.
The 2026 US cholesterol guideline supports selective calcium scoring in this setting, particularly for men from 40 and women from 45 whose estimated risk is borderline or intermediate and whose treatment decision remains uncertain. These ages identify people in whom the test may be considered; they are not a universal screening schedule. [4]
Ask what would happen after either result. Would finding calcium change treatment? Would a zero score change the plan? If treatment is already clearly indicated, the scan may add less to the decision.
What zero means—and what a high score means
A zero score means the scan did not detect coronary calcium. It can be reassuring in the right setting. Softer, noncalcified plaque can still be present, especially in younger adults, so zero does not mean every artery is free of disease. [1]
A positive score shows calcified plaque. It is not a percentage of blockage. A high score may strengthen the case for prevention, but it does not by itself show that an artery needs a procedure. Review the result with the ordering clinician, and do not stop prescribed treatment or dismiss symptoms because of a score.
Calcium scoring can improve a risk discussion without being the right screening test for everyone. The US Preventive Services Task Force’s assessment found insufficient evidence to settle the overall balance of benefits and harms of routinely adding it to traditional risk assessment in people without symptoms. The cardiology guideline’s selective use addresses a more focused treatment decision. [4] [5]
When angiography is useful
For chest symptoms, a clinician first considers urgency and the likelihood of coronary disease. US and European guidance support CCTA in selected situations; some people at low likelihood need no further imaging. [3] [10]
CCTA shows anatomy. A stress test asks how well the heart’s blood supply meets demand under stress. Sometimes a visible narrowing needs a further functional assessment to understand its importance. Persistent discomfort also needs attention when there is no major narrowing: the large coronary arteries do not explain every possible cause.
How seeing the arteries can change care
SCOT-HEART offers an encouraging example. The trial followed more than 4,100 people assessed for stable chest pain. Over about ten years, coronary death or a nonfatal heart attack occurred in 6.6% of those whose care included CCTA, compared with 8.2% receiving standard care—roughly one to two fewer events per 100 people. Preventive prescribing was more frequent after CCTA. [7]
The benefit belongs to that care strategy: seeing the arteries helped inform what happened next. The trial did not show a clear reduction in overall deaths, and it did not test routine scanning of everyone who feels well.
Other studies asked different questions. PROMISE compared CCTA with functional testing in people with symptoms and found no clear advantage in its main combined health outcome over about two years. FACTOR-64 examined screening people with diabetes who had no symptoms and did not establish a clear improvement in its main outcome. [8] [9]
A smaller SCOT-HEART 2 study suggests that seeing the coronary arteries may also help some people act on prevention. More participants receiving CCTA-guided care met a combined set of lifestyle goals after six months. That is promising, although it does not yet show fewer heart attacks. [12]
Prepare for the whole pathway
Both scans involve radiation, with dose depending on the person and protocol. Tell the team if pregnancy is possible. For CCTA, discuss kidney function, medicines and any previous contrast reaction. Follow the clinic’s preparation instructions. [1] [2]
CCTA is different from invasive coronary angiography, which passes a catheter through an artery to the heart. A narrowing cannot be treated during the CT scan itself. Heavy calcification or an irregular heart rhythm can also make the images harder to interpret.
Ask what happens if the scan finds something uncertain or unrelated to the original question. Further investigations can bring costs and anxiety as well as useful answers. Knowing who will explain the report and arrange follow-up makes the test more useful. [5]
Choose the test around the decision
At Healthy Longevity Clinic, our approach to physician-led preventive care starts with the decision the scan could improve. For one person, that may be confidence about prevention; for another, investigation of a symptom.
Our coronary CT service information for Prague describes angiography with contrast and plaque analysis. Confirm the exact examination, location and follow-up rather than relying on a general label such as “heart scan.” [11]
Bring previous heart-test reports and your medication list. The most useful question is what the result will change: treatment, further evaluation or reassurance grounded in your own circumstances.
What remains uncertain
A zero calcium score does not exclude noncalcified plaque or explain new chest symptoms. Imaging trials tested different care strategies, not the scan in isolation, and do not justify screening everyone. Both scans use radiation; angiography adds contrast-related considerations and possible follow-up investigations.
References
- Cardiac CT for calcium scoring.
- Coronary CTA.
- 2021 AHA/ACC Chest Pain Guideline Perspectives.
- Top Things to Know: 2026 Guideline on the Management of Dyslipidemia.
- Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors.
- Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring.
- Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
- Outcomes of anatomical versus functional testing for coronary artery disease.
- Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
- 2024 ESC Guidelines for the management of chronic coronary syndromes.
- Coronary CT angiography and plaque analysis
- CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy: A Nested Substudy of the SCOT-HEART 2 Randomized Clinical Trial.
Disclosure
Prepared with AI assistance. Healthy Longevity Clinic provides heart-health assessment services. The cited trials received public, charitable or institutional support; some also received industry funding or disclosed author relationships with imaging, device and pharmaceutical companies.